Concepedia

Cécile Bally

CB

Statistics

Publications

11

Citations

602

H-Index

10

Active since

2012

Affiliations

Assistance Publique – Hôpitaux de Paris(Current)

Université Paris Cité

Hôpital Saint-Louis

Université Sorbonne Paris Nord

Cécile Bally is an author at Assistance Publique – Hôpitaux de Paris specializing in medicine, chemotherapy, and myelodysplastic syndromes.

Publications per year

2012–2021

11

Publications

11

Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine

Cécile Bally, Lionel Adès, Aline Renneville et al. · Leukemia Research · 2014 · 159 citations

Medicine, Molecular Genetics, Oncology +17

Synergistic effects of PRIMA-1<sup>Met</sup> (APR-246) and 5-azacitidine in <i>TP53</i>-mutated myelodysplastic syndromes and acute myeloid leukemia

Nabih Maslah, Norman Salomao, Louis Drevon et al. · Haematologica · 2019 · 139 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Outcome of Acute Promyelocytic Leukemia (APL) in Children and Adolescents: An Analysis in Two Consecutive Trials of the European APL Group

Cécile Bally, Jehane Fadlallah, Guy Leverger et al. · Journal of Clinical Oncology · 2012 · 55 citations · Full text

Medicine, Oncology, Pediatrics +14

Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): A report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM)

Cécile Bally, Sylvain Thépot, Bruno Quesnel et al. · Leukemia Research · 2013 · 49 citations

Medicine, Oncology, Pharmacology +13

A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure

Marie Sébert, Aline Renneville, Cécile Bally et al. · Haematologica · 2019 · 49 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

1–5 of 11